ZeroEyes and Advantech Partner to Expand Delaware State University Campus Security with ZeroEyes’ AI Gun Detection Platform

University Enhances Safety with Multi-Layered Approach Leveraging Advantech’s Expertise in Security Systems Integration PHILADELPHIA, Feb. 25, 2025 /PRNewswire/ — ZeroEyes, the creators of the only AI-based gun detection video analytics platform that holds the full U.S. Department of Homeland Security SAFETY Act Designation, today announced Delaware State University (DSU) has integrated ZeroEyes’ AI gun detection… Continue reading ZeroEyes and Advantech Partner to Expand Delaware State University Campus Security with ZeroEyes’ AI Gun Detection Platform

MODV Securities Case Alert: ModivCare, Inc. Stockholders Should Contact Robbins LLP for Information About the Lead Plaintiff Deadline in the MODV Class Action Lawsuit

SAN DIEGO, Feb. 25, 2025 /PRNewswire/ — Robbins LLP reminds stockholders that a class action was filed on behalf of persons and entities that purchased or otherwise acquired ModivCare, Inc. (NASDAQ: MODV) securities between November 3, 2022 and September 15, 2024. ModivCare provides a suite of integrated supportive care solutions for public and private payors and… Continue reading MODV Securities Case Alert: ModivCare, Inc. Stockholders Should Contact Robbins LLP for Information About the Lead Plaintiff Deadline in the MODV Class Action Lawsuit

ERCOT Board approves moving ahead to finalize CenterPoint Energy’s emergency generation proposal; Company’s actions will lower bills for Houston-area customers and help avoid regional energy shortfall

CenterPoint’s 15 large emergency generation units will help ERCOT meet current and future energy needs for the San Antonio region for up to two years starting in Summer 2025 Greater Houston-area customers will see bill relief related to this transaction of approximately $2 less per month by 2027 Subject to final approvals, CenterPoint will make… Continue reading ERCOT Board approves moving ahead to finalize CenterPoint Energy’s emergency generation proposal; Company’s actions will lower bills for Houston-area customers and help avoid regional energy shortfall

FTAI Investors Have Opportunity to Lead FTAI Aviation Ltd. Securities Fraud Lawsuit

NEW YORK, Feb. 25, 2025 /PRNewswire/ —  Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of FTAI Aviation Ltd. (NASDAQ: FTAI) between July 23, 2024, and January 15, 2025, both dates inclusive (the “Class Period”), of the important March 18, 2025 lead plaintiff deadline. So what: If you purchased FTAI… Continue reading FTAI Investors Have Opportunity to Lead FTAI Aviation Ltd. Securities Fraud Lawsuit

Venture Global, Inc. (VG) Investors: April 18, 2025 Filing Deadline in Securities Class Action – Contact Kessler Topaz Meltzer & Check, LLP

RADNOR, Pa., Feb. 25, 2025 /PRNewswire/ — The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com)  informs investors that a securities class action lawsuit has been filed against Venture Global, Inc. (“Venture”) (NYSE: VG) on behalf of those who purchased Venture common stock pursuant and/or traceable to Venture’s registration statement and prospectus (collectively, the “IPO… Continue reading Venture Global, Inc. (VG) Investors: April 18, 2025 Filing Deadline in Securities Class Action – Contact Kessler Topaz Meltzer & Check, LLP

Interlace at Consensus 2025: Card Solutions Connect Global Web3 Firms in the “Year of Payfi”

SINGAPORE, Feb. 25, 2025 /PRNewswire/ — From February 18 to 20, 2025, Consensus Hong Kong took place at the Hong Kong Convention and Exhibition Centre, attracting global attention from the Web3 and fintech communities in what many are calling the “Year of PayFi” in the crypto industry. During the event, Interlace, a leading fintech infrastructure provider,… Continue reading Interlace at Consensus 2025: Card Solutions Connect Global Web3 Firms in the “Year of Payfi”

WABCOWÜRTH RELIES ON GETAC: RELIABLE COMMERCIAL VEHICLE DIAGNOSTICS UNDER TOUGH CONDITIONS

GETAC S410 LAPTOPS IN USE IN COMMERCIAL VEHICLE DIAGNOSTICS THROUGHOUT EUROPE TAIPEI, Feb. 25, 2025 /PRNewswire/ — WABCOWÜRTH Workshop Services GmbH, a joint venture between the Würth Group and the Commercial Vehicle Control Systems Division of the ZF Group, is using Getac S410 rugged laptops for increased efficiency of its multi-brand diagnostic systems for commercial vehicles… Continue reading WABCOWÜRTH RELIES ON GETAC: RELIABLE COMMERCIAL VEHICLE DIAGNOSTICS UNDER TOUGH CONDITIONS

Kessler Topaz Meltzer & Check, LLP Notifies Grocery Outlet Holding Corp. Investors of Upcoming Deadline in Securities Fraud Class Action Lawsuit

RADNOR, Pa., Feb. 25, 2025 /PRNewswire/ — The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com)  informs investors that a securities class action lawsuit has been filed against Grocery Outlet Holding Corp. (“Grocery Outlet”) (NASDAQ: GO)  on behalf of those who purchased or acquired Grocery Outlet securities between November 7, 2023, and May 7,… Continue reading Kessler Topaz Meltzer & Check, LLP Notifies Grocery Outlet Holding Corp. Investors of Upcoming Deadline in Securities Fraud Class Action Lawsuit

HBM Alpha Therapeutics Enters Strategic Collaboration and License Agreement to Advance Novel Endocrine Therapies

CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI , Feb. 25, 2025 /PRNewswire/ — HBM Alpha Therapeutics (HBMAT), Inc., an innovative biotechnology company incubated by Harbour BioMed (HKEX: 02142), announced a strategic collaboration and license agreement with a business partner to advance novel therapies targeting corticotropin-releasing hormone (CRH) for various disorders. Under the agreement, the partner gains exclusive global… Continue reading HBM Alpha Therapeutics Enters Strategic Collaboration and License Agreement to Advance Novel Endocrine Therapies

REGN INVESTOR NOTICE: Regeneron Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Securities Class Action Lawsuit

SAN DIEGO, Feb. 25, 2025 /PRNewswire/ — Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) securities between November 2, 2023 and October 30, 2024, both dates inclusive (the “Class Period”), have until Monday, March 10, 2025 to seek appointment as lead plaintiff of the Regeneron class… Continue reading REGN INVESTOR NOTICE: Regeneron Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Securities Class Action Lawsuit